mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |